Xellia Pharmaceuticals offers a range of Finished Dosage Form (FDF) products, primarily within the category of hospital injectables. Our portfolio of products contain some of the most important drugs used in the fight against infections with multi-drug resistant bacteria. Some of our FDF products are manufactured entirely by Xellia while others are manufactured through CMO partnerships.
For more detailed information, please reach out to our Sales Team.
-
Colistimethate sodium dry-filled vials
Used in the treatment of patients with serious infections due to selected aerobic Gram-negative pathogens with limited treatment options.
View product information -
Colistimethate sodium lyophilized vials
Used in the treatment of acute or chronic infections due to sensitive strains of Gram-negative pathogens. It is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa.
View product information -
Daptomycin vials
Used in the treatment of complicated skin and skin structure/soft-tissue infections caused by susceptible isolates of Gram-positive bacteria: Staphylococcus aureus (including MRSA-methicillin-resistant Staphylococcus aureus), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae supsp. equisimilis and Enterococcus faecalis (vancomycinsusceptible isolates only). Additionally used in the treatment of patients with bloodstream infections (bacteremia), including patients with right-sided infective endocarditis caused by Staphylococcus aureus.
View product information -
Micafungin vials
Micafungin is indicated for the treatment of blood stream Candida infections and disseminated candidiasis, esophageal candidiasis and for the prophylaxis of Candida infections (US) including in patients at risk of neutropenia (EU). Additionally, in US it is indicated for Candida peritonitis.
View product information -
Polymyxin B vials
Used in the treatment of patients with acute urinary, meningeal or blood-stream infections due to susceptible strains such as Pseudomonas aeruginosa, Haemophilus influenzae, Escherichia coli, Aerobacter aerogenes or Klebsiella pneumoniae.
View product information -
Vancomycin HCl vials
Used in the treatment of patients with severe and/or methicillin-resistant staphylococcal infections (endocarditis, bone infections, lower respiratory tract infections, septicemia and skin structure infections) and treatment of preoperative prophylaxis of streptococcal or diphteroid endocarditis where other antibiotics cannot be used due to intolerance or drug resistance.
View product information -
Vancomycin Injection
Used in the treatment of severe systemic methicillin resistant (MRSA) and sensitive strains where other antibiotics cannot be used due to intolerance or drug resistance; including septicemia, infective endocarditis, skin and skin structure infections, bone infections and lower respiratory tract infections.
View product information -
Voriconazole vials
Used in the treatment of patients with progressive, possibly life-threatening fungal infections such as candidaemia in non-neutropenic patients, invasive candidiasis in skin, abdomen, kidney, bladder wall and wounds, invasive aspergillosis and infections caused by Scedosporium spp and Fusarium spp in patients intolerant/refractory to other therapies. Can be used for prophylaxis in high risk allogeneic hematopoietic stem cell transplant recipients (EU only).
View product information
